Sesen Bio, Inc.
- Country
- 🇺🇸United States
- Ownership
- Public, Subsidiary
- Established
- 2010-01-01
- Employees
- 1
- Market Cap
- -
- Website
- https://sesenbio.com
Clinical Trials
5
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Vicinium Treatment for Subjects With Non-muscle Invasive Bladder Cancer Previously Treated With BCG
- Conditions
- Bladder Cancer
- First Posted Date
- 2015-05-20
- Last Posted Date
- 2023-07-24
- Lead Sponsor
- Sesen Bio, Inc.
- Target Recruit Count
- 133
- Registration Number
- NCT02449239
Study of the Safety of VB6-845 in Patients With Advanced Solid Tumours of Epithelial Origin
- First Posted Date
- 2007-06-04
- Last Posted Date
- 2023-03-23
- Lead Sponsor
- Sesen Bio, Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT00481936
- Locations
- 🇬🇪
Chemotherapy and Immunotherapy clinic Medulla, Tbilisi, Georgia
🇷🇺Blokhin Cancer Research Centre, Department of Chemotherapy and Combined therapy, Moscow, Russian Federation
🇷🇺Blokhin Cancer Research Centre, Department of Clinical Pharmacology and Chemotherapy, Moscow, Russian Federation
Study of Vicinium for Treating Patients With Non-Invasive Urothelial Carcinoma In Situ
- Conditions
- Bladder CancerBladder TumorsUrinary Bladder CancerBladder Neoplasms
- Interventions
- First Posted Date
- 2007-04-19
- Last Posted Date
- 2020-05-12
- Lead Sponsor
- Sesen Bio, Inc.
- Target Recruit Count
- 46
- Registration Number
- NCT00462488
- Locations
- 🇺🇸
Southeastern Research Group, Inc., Tallahassee, Florida, United States
🇺🇸Johns Hopkins Medical Institutions, Baltimore, Maryland, United States
🇺🇸Lawrenceville Urology, Lawrenceville, New Jersey, United States
Study of Proxinium Plus Best Supportive Care Versus Best Supportive Care for Patients With Advanced Head and Neck Cancer
- Conditions
- Neoplasms, Squamous CellCarcinoma, Squamous CellCarcinoma, Squamous Cell of Head and NeckHead and Neck NeoplasmsHead and Neck CancerMouth Neoplasms
- Interventions
- First Posted Date
- 2006-12-18
- Last Posted Date
- 2015-12-23
- Lead Sponsor
- Sesen Bio, Inc.
- Target Recruit Count
- 165
- Registration Number
- NCT00412776
- Locations
- 🇦🇷
Hospital Italiano Regional del Sur, Bahia Blanca, Argentina
🇦🇷Hospital Municipal de Agudos Leonidas Lucero, Bahia Blanca, Argentina
🇦🇷Centro de Estudio y Tratamiento de las Enfermedades Neoplasicas (CETEN), Buenos Aires, Argentina
Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer
- Conditions
- Squamous Cell Carcinoma of the Head and NeckHead and Neck CancerCarcinoma, Squamous CellMouth NeoplasmsNeoplasms, Squamous CellHead and Neck Neoplasms
- Interventions
- First Posted Date
- 2006-01-04
- Last Posted Date
- 2015-12-23
- Lead Sponsor
- Sesen Bio, Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT00272181
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
🇺🇸UCLA Medical Center, Los Angeles, California, United States